These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16316350)

  • 81. Beta arrestin-related signalling axes are influenced by dexamethasone and metformin in vascular smooth muscle cells cultured in high glucose condition.
    Soleimani AA; Shokri N; Elahimanesh M; Mohammadi P; Parvaz N; Bakhshandeh M; Najafi M
    Endocrinol Diabetes Metab; 2024 Jan; 7(1):e465. PubMed ID: 38102782
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis.
    Pickering RJ; Tikellis C; Rosado CJ; Tsorotes D; Dimitropoulos A; Smith M; Huet O; Seeber RM; Abhayawardana R; Johnstone EK; Golledge J; Wang Y; Jandeleit-Dahm KA; Cooper ME; Pfleger KD; Thomas MC
    J Clin Invest; 2019 Jan; 129(1):406-421. PubMed ID: 30530993
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Multiple Growth Factors, But Not VEGF, Stimulate Glycosaminoglycan Hyperelongation in Retinal Choroidal Endothelial Cells.
    Al Gwairi O; Osman N; Getachew R; Zheng W; Liang XL; Kamato D; Thach L; Little PJ
    Int J Biol Sci; 2016; 12(9):1041-51. PubMed ID: 27570478
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress.
    Sima AV; Botez GM; Stancu CS; Manea A; Raicu M; Simionescu M
    J Cell Mol Med; 2010 Dec; 14(12):2790-802. PubMed ID: 19818091
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
    J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Advanced glycation end-products enhance calcification in vascular smooth muscle cells.
    Ren X; Shao H; Wei Q; Sun Z; Liu N
    J Int Med Res; 2009; 37(3):847-54. PubMed ID: 19589269
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Apocynin decreases AGEs-induced stimulation of NF-κB protein expression in vascular smooth muscle cells from GK rats.
    Silva CO; da Silva OA; Duarte GP; Descomps B; Lahlou S
    Pharm Biol; 2015 Apr; 53(4):488-93. PubMed ID: 25471209
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis.
    Mao L; Yin R; Yang L; Zhao D
    Front Endocrinol (Lausanne); 2022; 13():983723. PubMed ID: 36120471
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The mechanism by which dietary AGEs are a risk to human health is via their interaction with RAGE: arguing against the motion.
    Heizmann CW
    Mol Nutr Food Res; 2007 Sep; 51(9):1116-9. PubMed ID: 17854011
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.
    Ballinger ML; Thomas MC; Nigro J; Ivey ME; Dilley RJ; Little PJ
    Kidney Int; 2005 Dec; 68(6):2756-65. PubMed ID: 16316350
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Receptors for advanced glycation end products and their physiological and clinical significance].
    Pietkiewicz J; Seweryn E; Bartyś A; Gamian A
    Postepy Hig Med Dosw (Online); 2008 Oct; 62():511-23. PubMed ID: 18936727
    [TBL] [Abstract][Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.